The platform is established at the Institute for Clinical Chemistry and Laboratory Medicine of University Hospital Dresden and contributes to the mission of NCT/UCC Dresden.
Alterations in cellular metabolism are a hallmark of many cancer types. Research in this context aims to understand the role of cellular metabolism in tumorigenesis as well as developing new tumor metabolism-related therapies.
Metabolomics is the comprehensive analysis of small molecules (i.e. metabolites) in body fluids, cells, tissues and tissue biopsies. To facilitate research into cancer metabolism, the Metabolomics Platform offers metabolite analysis using complementary methods, specifically nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).